{"title": "Andaluc\u00eda administrar\u00e1 una vacuna pionera a reci\u00e9n nacidos a partir de oto\u00f1o", "author": "Pablo Salvador", "url": "https://theobjective.com/espana/andalucia/2023-07-25/andalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs/", "hostname": "theobjective.com", "description": "La consejera de Salud y Consumo de la Junta de Andaluc\u00eda, Catalina Garc\u00eda, ha anunciado la implementaci\u00f3n de la vacuna del Virus Respiratorio Sincitial en", "sitename": "The Objective", "date": "2023-07-25", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Andaluc\u00eda administrar\u00e1 una vacuna pionera a reci\u00e9n nacidos a partir de oto\u00f1o\nLa Junta de Andaluc\u00eda refuerza su sistema de vacunaci\u00f3n con la inmunizaci\u00f3n ante el Virus Respiratorio Sincitial (VRS)\nLa consejera de Salud y Consumo de la\n[Junta de Andaluc\u00eda](https://theobjective.com/etiqueta/junta-de-andalucia/), Catalina Garc\u00eda, ha anunciado la implementaci\u00f3n de la [vacuna](https://theobjective.com/etiqueta/vacunas/) del Virus Respiratorio Sincitial en los menores de seis meses a partir del pr\u00f3ximo oto\u00f1o. La Junta de Andaluc\u00eda ha informado que se inmunizar\u00e1 a todos los [ni\u00f1os](https://theobjective.com/etiqueta/ninos/) que nazcan desde el 1 de octubre de 2023 al 31 de marzo de 2024, en sus primero d\u00edas. Tambi\u00e9n se les administrar\u00e1 a los lactantes nacidos entre el 1 de abril y el 30 de septiembre de 2023.\nLa estimaci\u00f3n de la campa\u00f1a 2023-2024 es que reciban la vacuna un total de 60.000 lactantes en Andaluc\u00eda. Catalina Garc\u00eda ha explicado que la vacuna se ofrecer\u00e1 tambi\u00e9n a aquellos menores de un a\u00f1o con antecedentes de prematuridad de 25 semanas, as\u00ed como a otros lactantes, de hasta 24 meses, con\n[patolog\u00edas](https://theobjective.com/etiqueta/enfermedades/) de muy alto riesgo.\nLa vacuna se empezar\u00e1 a administrar a principios de\n[oto\u00f1o](https://theobjective.com/etiqueta/otono/). Samuel Salvador, enfermero especialista en ginecolog\u00eda y obstetricia \u2014matr\u00f3n\u2014 en atenci\u00f3n primaria del SAS, asegura que las afecciones respiratorias son las principales causas del ingreso hospitalario de los reci\u00e9n nacidos. El Virus Respiratorio Sincitial, seg\u00fan ha explicado a [THE OBJECTIVE](https://theobjective.com/) Samuel Salvador, tiene una mayor incidencia en las \u00e9pocas estacionales de oto\u00f1o e [invierno](https://theobjective.com/etiqueta/invierno/) y ataca principalmente a las v\u00edas respiratorias, desencadenando en bronquiolitis o [neumon\u00eda](https://theobjective.com/etiqueta/neumonia/).\nLos menores de seis meses reflejan una mayor vulnerabilidad en su sistema inmunol\u00f3gico. Ese es el principal motivo por el que se trata de blindar a este sector de la poblaci\u00f3n con la vacuna del Virus Respiratorio Sincitial. Adem\u00e1s, la \u00e9poca en la que este virus\n[tiene mayor incidencia coincide con la llegada de la gripe](https://theobjective.com/sociedad/2023-04-28/gripe-neumonia-bacteriana/), lo que podr\u00eda ser muy perjudicial para la salud de un menor. La gripe tambi\u00e9n est\u00e1 recogida en el calendario de vacunaci\u00f3n andaluz y se administra a la poblaci\u00f3n infantil de 6 meses a 4 a\u00f1os.\nSeg\u00fan ha dado a conocer Catalina Garc\u00eda, a finales de noviembre del pasado a\u00f1o se alcanzaron en\n[Andaluc\u00eda](https://theobjective.com/espana/andalucia/) un total de 301 ni\u00f1os ingresados, de los cuales 36 tuvieron que ser atendidos en la UCI. Samuel Salvador ha asegurado que esta vacunaci\u00f3n permitir\u00e1 reducir el n\u00famero de ingresos hospitalarios, lo que se traducir\u00e1 en un descenso del gasto econ\u00f3mico en la sanidad p\u00fablica.\nCatalina Garc\u00eda, tambi\u00e9n se refiri\u00f3 a la incidencia econ\u00f3mica que la vacunaci\u00f3n podr\u00eda tener: \u00abSe trata de una medida que puede producir un gran impacto a\n[nivel sanitario](https://theobjective.com/etiqueta/sanidad-publica/), ya que ayudar\u00eda a disminuir notablemente una de las patolog\u00edas m\u00e1s frecuentes y costosas de cada oto\u00f1o-invierno\u00bb.\nEl medicamento, llamado Nirsevimab, con el nombre comercial de Beyfortus, ser\u00e1 administrado por v\u00eda intramuscular en una sola dosis. Ya est\u00e1 autorizado para su uso en la\n[Uni\u00f3n Europea](https://theobjective.com/etiqueta/union-europea/) desde el 31 de octubre de 2022, aunque no estar\u00e1 disponible en nuestro pa\u00eds hasta finales de septiembre de este a\u00f1o.\nSeg\u00fan Samuel Salvador, enfermero especialista en ginecolog\u00eda y obstetricia \u2013 matr\u00f3n \u2013 en atenci\u00f3n primaria del SAS, Andaluc\u00eda es una de las comunidades aut\u00f3nomas con mayor fortaleza en el \u00e1mbito de la vacunaci\u00f3n: \u00abAndaluc\u00eda est\u00e1 bastante actualizada y lo demuestra esta vacunaci\u00f3n pionera en el Virus Respiratorio Sincitial, junto con el de la gripe en mayores de 6 meses. Creo que se est\u00e1 haciendo una labor muy importante\u00bb.\nDesde el Servicio Andaluz de Salud se est\u00e1 tratando de dar cada vez m\u00e1s importancia a una vacunaci\u00f3n activa desde edades tempranas. La concienciaci\u00f3n forma parte de este objetivo. Seg\u00fan los datos ofrecidos por la Junta de Andaluc\u00eda, en el primer a\u00f1o de administraci\u00f3n de la vacuna infantil de la gripe, \u00abse ha llegado a m\u00e1s del 45% de la poblaci\u00f3n diana\u00bb.\nLa primera causa de ingreso\n[hospitalario](https://theobjective.com/etiqueta/hospitales/) en menores de 6 meses son las afecciones respiratorias, seguido de causas digestivas y urinarias. Seg\u00fan Samuel Salvador, la lactancia materna es un factor clave para mejorar el sistema inmunol\u00f3gico de los reci\u00e9n nacidos. Sin embargo, en muchas ocasiones no es suficiente, y un sistema de vacunaci\u00f3n fuerte es una de las mejores medidas para reducir la mortalidad infantil.\nEl Virus Respiratorio Sincitial es una enfermedad\n[viral](https://theobjective.com/etiqueta/virus/) com\u00fan. Puede provocar infecciones pulmonares graves no solo en ni\u00f1os, sino tambi\u00e9n en adultos o personas mayores. Los [s\u00edntomas](https://theobjective.com/etiqueta/sintomas/) son parecidos a los de un resfriado: congesti\u00f3n nasal, tos o fiebre, entre otros, y se suelen dar por diferentes etapas. Los m\u00e1s peque\u00f1os pueden estar propagando el virus durante varias semanas. La vacuna administrada en Andaluc\u00eda ayudar\u00e1 al sistema inmunitario de los ni\u00f1os a reducir la incidencia de esta enfermedad viral.", "language": null, "image": "https://theobjective.com/wp-content/uploads/2023/07/contactophoto-0731309389-scaled.jpg", "pagetype": "article", "links": ["https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://theobjective.com", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com", "https://twitter.com/TheObjective_es", "https://www.instagram.com/theobjective_Es/", "https://www.facebook.com/theobjective.esp", "https://www.youtube.com/c/TheObjective_es", "https://open.spotify.com/user/theobjective_es?si=m4YyKsRFSKaAd11iC1pJrA", "https://es.linkedin.com/company/the-objective-media", "https://medium.com/@TheObjective", "https://www.tiktok.com/@theobjective", "https://theobjective.com/", "https://theobjective.com/espana/", "https://theobjective.com/etiqueta/elecciones-generales/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/castilla-y-leon/", "https://theobjective.com/etiqueta/comunidad-de-madrid/", "https://theobjective.com/etiqueta/comunidad-valenciana/", "https://theobjective.com/etiqueta/pais-vasco/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/cultura/", "https://theobjective.com/etiqueta/literatura/", "https://theobjective.com/etiqueta/musica/", "https://theobjective.com/etiqueta/cine/", "https://theobjective.com/etiqueta/arte/", "https://theobjective.com/etiqueta/series/", "https://theobjective.com/sociedad/", "https://theobjective.com/etiqueta/salud/", "https://theobjective.com/sociedad/medioambiente/", "https://theobjective.com/lifestyle/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/recetas/", "https://theobjective.com/etiqueta/vinos/", "https://theobjective.com/etiqueta/restaurantes/", "https://theobjective.com/gente/", "https://theobjective.com/etiqueta/celebrities/", "https://theobjective.com/etiqueta/casa-real/", "https://theobjective.com/internacional/", "https://theobjective.com/etiqueta/guerra-ucrania-rusia/", "https://theobjective.com/deportes/", "https://theobjective.com/etiqueta/futbol/", "https://theobjective.com/etiqueta/formula-1/", "https://theobjective.com/etiqueta/baloncesto/", "https://theobjective.com/etiqueta/tenis/", "https://theobjective.com/etiqueta/golf/", "https://theobjective.com/motor/", "https://theobjective.com/etiqueta/coches/", "https://theobjective.com/etiqueta/motos/", "https://theobjective.com/etiqueta/movilidad/", "https://theobjective.com/etiqueta/dgt/", "https://theobjective.com/tecnologia/", "https://theobjective.com/tecnologia/videojuegos/", "https://theobjective.com/etiqueta/internet/", "https://theobjective.com/etiqueta/smartphones/", "https://theobjective.com/etiqueta/redes-sociales/", "https://theobjective.com/etiqueta/historia/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/medios/", "https://theobjective.com/medios/television/", "https://theobjective.com/medios/radio/", "https://theobjective.com/etiqueta/programas/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/videos/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/etiqueta/el-purgatorio/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/podcasts/", "https://theobjective.com/etiqueta/al-tanto/", "https://theobjective.com/etiqueta/el-gris-importa/", "https://theobjective.com/etiqueta/sumario-de-tarde/", "https://theobjective.com/galerias/", "https://theobjective.com/productos-recomendados/", "https://informativoscanarias.theobjective.com/", "https://classpaper.theobjective.com/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/principios-y-valores/", "https://theobjective.com/equipo/", "https://theobjective.com/firmas/", "https://theobjective.com/app/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/newsletters", "https://theobjective.com/apoya-a-the-objective", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/autor/pablo-salvador/", "https://theobjective.com/autor/pablo-salvador/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F&text=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o&via=TheObjective_es", "//web.whatsapp.com/send?text=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o | The Objective%20https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F&title=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F&text=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o%20The Objective", "/cdn-cgi/l/email-protection#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", "https://theobjective.com/etiqueta/junta-de-andalucia/", "https://theobjective.com/etiqueta/vacunas/", "https://theobjective.com/etiqueta/ninos/", "https://theobjective.com/etiqueta/enfermedades/", "https://theobjective.com/etiqueta/otono/", "https://theobjective.com/", "https://theobjective.com/etiqueta/invierno/", "https://theobjective.com/etiqueta/neumonia/", "https://theobjective.com/sociedad/2023-04-28/gripe-neumonia-bacteriana/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/etiqueta/sanidad-publica/", "https://theobjective.com/economia/2023-07-03/gsk-vacuna-gonorrea-casos-europa-eeuu/", "https://theobjective.com/economia/2023-07-03/gsk-vacuna-gonorrea-casos-europa-eeuu/", "https://theobjective.com/etiqueta/union-europea/", "https://theobjective.com/sociedad/2023-07-12/alivio-dolor-nuevas-tecnologias-farmacos/", "https://theobjective.com/sociedad/2023-07-12/alivio-dolor-nuevas-tecnologias-farmacos/", "https://theobjective.com/etiqueta/hospitales/", "https://theobjective.com/etiqueta/virus/", "https://theobjective.com/etiqueta/sintomas/", "https://theobjective.com/lifestyle/2022-12-13/gripe-resfriado-no-hacer/", "https://theobjective.com/lifestyle/2022-12-13/gripe-resfriado-no-hacer/", "https://theobjective.com/autor/pablo-salvador/", "https://theobjective.com/autor/pablo-salvador/", "https://theobjective.com/autor/pablo-salvador/", "//www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F", "//twitter.com/intent/tweet?url=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F&text=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o&via=TheObjective_es", "//web.whatsapp.com/send?text=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o | The Objective%20https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F", "https://www.linkedin.com/shareArticle?mini=true&url=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F&title=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o", "//telegram.me/share/url?url=https%3A%2F%2Ftheobjective.com%2Fespana%2Fandalucia%2F2023-07-25%2Fandalucia-vacuna-recien-nacidos-virus-respiratorio-sincitial-vrs%2F&text=Andaluc%C3%ADa%20administrar%C3%A1%20una%20vacuna%20pionera%20a%20reci%C3%A9n%20nacidos%20a%20partir%20de%20oto%C3%B1o%20The Objective", "/cdn-cgi/l/email-protection#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", "https://news.google.com/publications/CAAiELumQ8m_nwDuO-xzhLPkxhgqFAgKIhC7pkPJv58A7jvsc4Sz5MYY?ceid=ES:es&oc=3", "https://theobjective.com/etiqueta/andalucia/", "https://theobjective.com/etiqueta/bebes/", "https://theobjective.com/etiqueta/ninos/", "https://theobjective.com/etiqueta/sanidad-publica/", "https://theobjective.com/etiqueta/vacunacion/", "https://theobjective.com/etiqueta/vacunas/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/espana/", "https://theobjective.com/espana/politica/", "https://theobjective.com/espana/tribunales/", "https://theobjective.com/etiqueta/madrid/", "https://theobjective.com/etiqueta/cataluna/", "https://theobjective.com/espana/andalucia/", "https://theobjective.com/economia/", "https://theobjective.com/etiqueta/macroeconomia/", "https://theobjective.com/etiqueta/banca/", "https://theobjective.com/etiqueta/telecos/", "https://theobjective.com/etiqueta/energia/", "https://theobjective.com/etiqueta/transporte/", "https://theobjective.com/elsubjetivo/", "https://theobjective.com/elsubjetivo/opinion/", "https://theobjective.com/autor/alvaro-nieto/", "https://theobjective.com/autor/felix-de-azua/", "https://theobjective.com/autor/fernando-savater/", "https://theobjective.com/autor/antonio-cano/", "https://theobjective.com/sociedad/", "https://theobjective.com/cultura/", "https://theobjective.com/deportes/", "https://theobjective.com/internacional/", "https://theobjective.com/economia/consumo/", "https://theobjective.com/lifestyle/", "https://theobjective.com/gastronomia/", "https://theobjective.com/etiqueta/moda/", "https://theobjective.com/etiqueta/belleza/", "https://theobjective.com/etiqueta/sexualidad/", "https://theobjective.com/gente/", "https://theobjective.com/videos/", "https://theobjective.com/podcasts/", "https://theobjective.com/ultimas-noticias/", "https://theobjective.com/etiqueta/entrevistas/", "https://theobjective.com/branded-content/", "https://theobjective.com/etiqueta/vidas-cruzadas/", "https://theobjective.com/etiqueta/contraluz/", "https://theobjective.com/etiqueta/la-mirilla/", "https://theobjective.com/etiqueta/el-buzon-secreto/", "https://theobjective.com/etiqueta/historias-de-la-historia/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/newsletters/", "https://theobjective.com/apoya-a-the-objective/", "https://theobjective.com/escuela-ethos/", "https://theobjective.com/quienes-somos/", "https://theobjective.com/equipo/", "https://theobjective.com/politica-de-privacidad/", "https://theobjective.com/politica-de-cookies/", "https://theobjective.com/aviso-legal/", "https://theobjective.com/contactanos/", "https://theobjective.com/newsletters", "https://theobjective.com/terminos-y-condiciones", "https://theobjective.com/politica-de-privacidad", "https://theobjective.com"]}